Chemotherapy-Induced Peripheral Neuropathy (CIPN) and its Treatment: An NIH Collaboratory Study of Claims Data

    Details
    Basic Details
    Date
    Saturday, September 7, 2019
    Entity
    NIH
    Type
    Publication
    Description

    Chemotherapy-induced peripheral neuropathy (CIPN) is a disabling complication of many chemotherapies. We investigated the feasibility of using health plan claims and administrative data to identify CIPN occurrence by comparing patients who received neurotoxic and non-neurotoxic chemotherapies. The sample included over 53,000,000 patients from two regional and one national insurer in the USA (> 400,000 exposed to chemotherapy). Peripheral neuropathy was identified using a broad definition (definition 1) and a specific definition (i.e., drug-induced polyneuropathy code) (definition 2).

    Contributors
    Author(s)

    Jennifer Gewandter, Amber Kleckner, James Marshall, Jeffrey S. Brown, Lesley Curtis, Javier Bautista, Robert Dworkin, Ian Kleckner, Noah Kolb, Supriya Mohile, Karen Mustian